166 related articles for article (PubMed ID: 6187917)
1. Ovarian tumor antigens.
Benson MD; Lurain JR; Newton M
J Reprod Med; 1983 Jan; 28(1):17-23. PubMed ID: 6187917
[TBL] [Abstract][Full Text] [Related]
2. Tumor markers for ovarian cancer.
Bhattacharya M; Barlow JJ
Int Adv Surg Oncol; 1979; 2():155-76. PubMed ID: 95453
[TBL] [Abstract][Full Text] [Related]
3. Tumour markers in ovarian cancer.
van Nagell JR
Clin Obstet Gynaecol; 1983 Aug; 10(2):197-212. PubMed ID: 6193919
[No Abstract] [Full Text] [Related]
4. [The present status of tumor markers in malignant ovarian tumor].
Nishimura H; Miyoshi T; Hamai J; Miyahara K
Gan No Rinsho; 1985 May; 31(6 Suppl):589-93. PubMed ID: 2411960
[TBL] [Abstract][Full Text] [Related]
5. The value of tumor markers in cancer of the ovary.
Cantarow WD; Stolbach LL; Bhattacharya M; Chatterjee SK; Barlow JJ
Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):1095-8. PubMed ID: 6170620
[No Abstract] [Full Text] [Related]
6. [Ovarian cancer: markers, hormones receptors, immunological status].
Martin PM
Bull Cancer; 1982; 69(3):248-56. PubMed ID: 6181836
[TBL] [Abstract][Full Text] [Related]
7. Significance of the presence of tumor associated antigens in the clinical evolution of the ovarian carcinoma: analysis of 13 cases in stage III and IV.
Sacco F; Benedetti Panici P; Margariti PA; Di Roberto P; Maiorca A; Muscatello P; Villani L; Iacobelli S
Eur J Gynaecol Oncol; 1980 Dec; 1(3):136-9. PubMed ID: 6176449
[No Abstract] [Full Text] [Related]
8. Tumor antigens in ovarian malignancy.
Rubin SC; Lewis JL
Clin Obstet Gynecol; 1986 Sep; 29(3):693-704. PubMed ID: 2428553
[No Abstract] [Full Text] [Related]
9. Tumour-associated antigens for cystadenocarcinoma of the ovary.
Barlow JJ; Bhattacharya M
Clin Obstet Gynaecol; 1983 Aug; 10(2):187-96. PubMed ID: 6413113
[TBL] [Abstract][Full Text] [Related]
10. [Tumor markers in epithelial ovarian cancer].
Di Cocco B; Calabretta F; Alghisi F; Salesi N; Bossone G
Minerva Ginecol; 2003 Aug; 55(4):327-32. PubMed ID: 14581857
[TBL] [Abstract][Full Text] [Related]
11. The immune system in gynecologic malignancies.
Barber HR; Dorsett B
Prog Clin Biol Res; 1981; 70():357-69. PubMed ID: 6171833
[No Abstract] [Full Text] [Related]
12. [Possibilities and limitations of the clinical use of specific monoclonal antibodies for epithelial ovarian carcinomas: CA125K].
Pozzi V; D'Onofrio T; Cappa F; Mascaretti G; Meggiorini ML; Nusiner MP; Danese M
Minerva Ginecol; 1985 May; 37(5):253-7. PubMed ID: 3861960
[No Abstract] [Full Text] [Related]
13. Overview of oncofetal antigens in cancer.
Wepsic HT
Ann Clin Lab Sci; 1983; 13(4):261-6. PubMed ID: 6194734
[TBL] [Abstract][Full Text] [Related]
14. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
Suzuki H; Teshima K; Noda K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
[TBL] [Abstract][Full Text] [Related]
15. Tumor marker in ovarian cancer. Tumor-associated antigen.
Barlow JJ; Bhattacharya M
N Y State J Med; 1977 Mar; 77(3):342-3. PubMed ID: 265013
[No Abstract] [Full Text] [Related]
16. Anti-tumor antibodies in ovarian cancer.
Luborsky JL; Barua A; Shatavi SV; Kebede T; Abramowicz J; Rotmensch J
Am J Reprod Immunol; 2005 Aug; 54(2):55-62. PubMed ID: 16105096
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemically detecting target antigens in patient biopsies for tailoring monoclonal antibody based cancer therapy.
Smith NL; Finley JL; Wennerberg AE; Semer DA; Kearse KP
Hum Antibodies; 1999; 9(1):61-5. PubMed ID: 10331187
[TBL] [Abstract][Full Text] [Related]
18. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
Esheba GE; Pate LL; Longacre TA
Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
[TBL] [Abstract][Full Text] [Related]
19. Serum tumor markers.
Perkins GL; Slater ED; Sanders GK; Prichard JG
Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
[TBL] [Abstract][Full Text] [Related]
20. Application of Bayesian modeling of autologous antibody responses against ovarian tumor-associated antigens to cancer detection.
Erkanli A; Taylor DD; Dean D; Eksir F; Egger D; Geyer J; Nelson BH; Stone B; Fritsche HA; Roden RB
Cancer Res; 2006 Feb; 66(3):1792-8. PubMed ID: 16452240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
